Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 270

1.

Estimated benefits of glycemic control in microvascular complications in type 2 diabetes.

Vijan S, Hofer TP, Hayward RA.

Ann Intern Med. 1997 Nov 1;127(9):788-95.

PMID:
9382399
2.

Estimating the microvascular benefits of screening for type 2 diabetes mellitus.

Hofer TP, Vijan S, Hayward RA.

Int J Technol Assess Health Care. 2000 Summer;16(3):822-33.

PMID:
11028137
3.

Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.

Abraira C, Duckworth W, McCarren M, Emanuele N, Arca D, Reda D, Henderson W; VA Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2.

J Diabetes Complications. 2003 Nov-Dec;17(6):314-22.

PMID:
14583175
4.

Glycemic control and the risk of multiple microvascular diabetic complications.

Schellhase KG, Koepsell TD, Weiss NS.

Fam Med. 2005 Feb;37(2):125-30.

6.
7.

Importance of glucose control.

Edelman SV.

Med Clin North Am. 1998 Jul;82(4):665-87. Review.

PMID:
9706116
8.

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia.

Eastman RC, Javitt JC, Herman WH, Dasbach EJ, Copley-Merriman C, Maier W, Dong F, Manninen D, Zbrozek AS, Kotsanos J, Garfield SA, Harris M.

Diabetes Care. 1997 May;20(5):735-44.

PMID:
9135935
9.

Diabetes and cardiovascular disease: the role of glycemic control.

Cheng AY, Leiter LA.

Curr Diab Rep. 2009 Feb;9(1):65-72.

PMID:
19192427
10.

Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians.

Qaseem A, Vijan S, Snow V, Cross JT, Weiss KB, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians.

Ann Intern Med. 2007 Sep 18;147(6):417-22.

PMID:
17876024
12.

Care of adults with type 2 diabetes mellitus. A review of the evidence.

O'Connor PJ, Spann SJ, Woolf SH.

J Fam Pract. 1998 Nov;47(5 Suppl):S13-22. Review.

PMID:
9834750
13.

Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications.

Yokoyama H, Okudaira M, Otani T, Takaike H, Miura J, Saeki A, Uchigata Y, Omori Y.

Diabetes Care. 1997 May;20(5):844-7.

PMID:
9135953
14.

Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.

Nordwall M, Arnqvist HJ, Bojestig M, Ludvigsson J.

Pediatr Diabetes. 2009 May;10(3):168-76. doi: 10.1111/j.1399-5448.2008.00472.x. Epub 2008 Oct 22.

PMID:
19175900
15.

Cost-effectiveness of glycemic control and ophthalmological care in diabetic retinopathy.

Polak BC, Crijns H, Casparie AF, Niessen LW.

Health Policy. 2003 Apr;64(1):89-97.

PMID:
12644331
16.

The effects of improved glycemic control on complications in type 2 diabetes.

Gaster B, Hirsch IB.

Arch Intern Med. 1998 Jan 26;158(2):134-40. Review.

PMID:
9448551
17.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

18.

The relationship between glycemic control and platelet activity in type 2 diabetes mellitus.

Demirtunc R, Duman D, Basar M, Bilgi M, Teomete M, Garip T.

J Diabetes Complications. 2009 Mar-Apr;23(2):89-94. doi: 10.1016/j.jdiacomp.2008.01.006. Epub 2008 Mar 20.

PMID:
18358749
19.

Relation of glycemic control to diabetic complications and health outcomes.

Klein R, Klein BE.

Diabetes Care. 1998 Dec;21 Suppl 3:C39-43.

PMID:
9850488
20.

Predictors of abnormal cardiovascular autonomic function measured by frequence domain analysis of heart rate variability and conventional tests in patients with type 1 diabetes.

Mäkimattila S, Schlenzka A, Mäntysaari M, Bergholm R, Summanen P, Saar P, Erkkilä H, Yki-Järvinen H.

Diabetes Care. 2000 Nov;23(11):1686-93.

Supplemental Content

Support Center